US Stock MarketDetailed Quotes

QNRX Quoin Pharmaceuticals

Watchlist
  • 0.8099
  • -0.0091-1.11%
Close Dec 4 16:00 ET
  • 0.7613
  • -0.0486-6.00%
Post 19:35 ET
4.09MMarket Cap-221P/E (TTM)

Quoin Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quoin Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.44
-0.47
-0.03
Miss Est.
+77.44%
+75.90%
-6.84%
Analyst Rating
Buy

Nov 30, 2024

Quoin Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 13, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 13, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Quoin Pharmaceuticals Earnings Reports

  • Quoin Pharmaceuticals | 8-K: Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results

    Nov 8 16:11 ET

  • Quoin Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 8 11:29 ET

  • Quoin Pharmaceuticals | 8-K: Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results

    Aug 14 12:43 ET

  • Quoin Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.34%